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Although deposition of uric acid (UA) crystals is
known as the cause of gout, it is unclear whether
UA plays a role in other inflammatory diseases. We
here have shown that UA is released in the airways
of allergen-challenged asthmatic patients and mice,
where it was necessary for mounting T helper 2
(Th2) cell immunity, airway eosinophilia, and bron-
chial hyperreactivity to inhaled harmless proteins
and clinically relevant house dust mite allergen.
Conversely, administration of UA crystals together
with protein antigen was sufficient to promote Th2
cell immunity and features of asthma. The adjuvant
effects of UA did not require the inflammasome
(Nlrp3, Pycard) or the interleukin-1 (Myd88, IL-1r)
axis. UA crystals promoted Th2 cell immunity by acti-
vating dendritic cells through spleen tyrosine kinase
and PI3-kinase d signaling. These findings provide
further molecular insight into Th2 cell development
and identify UA as an essential initiator and amplifier
of allergic inflammation.
INTRODUCTION
Allergic asthma is caused by an inappropriate adaptive T helper 2
(Th2) cell-mediated immune response to innocuous antigen,
leading to eosinophilic airway inflammation, mucus hypersecre-
tion, structural changes to the airway wall, and variable airway
obstruction (Barnes, 2008). The cytokines produced by
allergen-specific Th2 cell-type lymphocytes are held largely
responsible for orchestrating themany featuresof asthma.Sensi-
tization results from allergen recognition by structural cells of the
airways and innate immunecells like basophils anddendritic cells
(DCs) that induce and amplify adaptive Th2 cell-mediatedimmune responses (Barrett and Austen, 2009; Hammad et al.,
2009, 2010; Lambrecht and Hammad, 2009; Sokol et al., 2008).
The precise molecular mechanisms involved in allergenicity
and Th2 cell response induction by DCs are incompletely under-
stood (Paul and Zhu, 2010). Allergens have a complex molecular
structure and often display enzymatic activity that stimulates
epithelial and innate immune cells through protease-activated
receptors (Hammad and Lambrecht, 2008; Sokol et al., 2008;
Tang et al., 2010), whereas others like house dust mite (HDM)
contain endotoxin or other pathogen-associated microbial
patterns (PAMPS) that trigger epithelial cells and/or DCs in
a toll-like receptor 4 (TLR4)- or C-type lectin receptor-dependent
manner (Hammad et al., 2009; Nathan et al., 2009; Trompette
et al., 2009). Triggering of PAMP receptors on epithelial cells
and/or basophils subsequently leads to release of innate pro-
Th2 cell cytokines like thymic stromal lymphopoietin (TSLP),
granulocyte-macrophage colony stimulating factor (GM-CSF),
IL-25, and IL-33 that instruct DCs to promote Th2 cell-type
immunity in the mediastinal lymph nodes (Hammad and Lam-
brecht, 2008;Hammadet al., 2009, 2010; Rank et al., 2009; Sokol
et al., 2008; Zhou et al., 2005).
Althoughcontamination of allergenswithPAMPs that stimulate
pattern recognition receptors provides a good explanation for
how immunity can be induced to harmless allergens, another
could be that allergens trigger release of damage-associated
molecular patterns (DAMPs) that occur intracellularly in homeo-
stasis but are released extracellularly upon physical or metabolic
stress (Matzinger, 2002). A well-known DAMP is uric acid (UA)
released from dying or stressed cells (Shi et al., 2003; Vorbach
et al., 2003). Uric acid crystals potently trigger acute neutrophilic
inflammation through stimulation of the NLRP3 inflammasome
and release of interleukin-1b (Chen et al., 2006; Martinon et al.,
2006). This pathway is at the heart of gouty inflammation, as
supported by the absence of UA-induced neutrophilic inflamma-
tion in mice lacking the NLRP3, ASC (Pycard), IL-1R, or its down-
stream adaptor MyD88 and by the success of IL-1 receptor
antagonist (IL-1RA) treatment for gout. We have reported
recently that UA is released in the peritoneal cavity after injectionImmunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc. 527
Figure 1. UA Is Necessary and Sufficient for Th2 Cell Response Induction to Ovalbumin
(A) In vitro bone marrow-derived GM-CSF-cultured DCs were stimulated with OVA or OVA+alum in the presence or absence of uricase (0.1 U/ml). In vivo, OVA or
OVA+alumwithorwithout50Uuricasewas injected intraperitoneally (i.p.).Bioactive IL-1bwasmeasured in thesupernatantor theperitoneal lavage2hrafterexposure.
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Uric Acid as a Trigger of Th2 Cell Immunityof the Th2 cell adjuvant aluminum hydroxide or alum, commonly
coinjected with harmless antigens intraperitoneally to induce
allergic sensitization and asthma (Kool et al., 2008b). In addition
to inducing release of UA, alum can also directly trigger
the NLRP3 inflammasome and stimulate secretion of bioactive
IL-1b (Eisenbarth et al., 2008; Kool et al., 2008a; Li et al., 2008;
McKee et al., 2009). These studies have aroused interest in
the UA-inflammasome-IL-1 axis as a trigger of Th2 cell
development.
Here, we hypothesized that uric acid is a general inducer and
amplifier of Th2 cell immunity. By using models of intraperitoneal
injection, as well as airway exposure of HDM allergen in mice
and patients, we found that UA is present at sites of Th2 cell
development, where it is necessary and sufficient for induction
of Th2 cell immunity. Contrary to expectation, this Th2 cell adju-
vant effect did not require triggering of the NLRP3-ASC complex,
nor signaling through the IL-1R. Rather, UA induced Th2 cell
immunity by triggering DC activation in a spleen tyrosine kinase
(Syk)- and PI3-kinase d-dependent manner. These findings
identify UA as an unexpected initiator and amplifier of Th2 cell
immunity and allergic inflammation.
RESULTS
Uric Acid Is Necessary and Sufficient for Induction
of Th2 Cell Immunity to Harmless Antigen
We have reported that UA is released in the peritoneal cavity
after injection of alum (Kool et al., 2008b) and is a necessary
intermediate for early DC activation in vivo, whereas others
argued that the immunostimulatory effects of alum did not
require UA (Franchi and Nu´n˜ez, 2008). As shown in Figure 1A,
the degradation of UA by uricase treatment reduced secretion
of bioactive IL-1b into the peritoneal cavity, whereas production
of IL-1b by DCs in vitro did not require endogenous release of
UA. Therefore, the important role of UA in mediating the adjuvant
activity of alum is mainly revealed in vivo. The increased UA
production after injection of OVA in alum was found to be intact
in Tlr4/, Myd88/, and Casp1/ mice, excluding an impor-
tant role for the TLR4 or inflammasome-IL1b axis in its induction
(Figure S1 available online).
Because alum is frequently used to induce allergy in animal
models of asthma, we hypothesized that UA is necessary for
promoting adaptive Th2 cell immunity to OVA+alum. Injection
of OVA+alum into BALB/c mice led to an increased concentra-
tion of UA in the peritoneal cavity, which could be neutralized(B) UA in the peritoneal lavage 2 hr after injection of OVA or OVA+alum in mice t
(C) BALB/c mice were treated with PBS or uricase 5min before sensitization with O
challenged with OVA aerosols on days 17–19. On day 20, BAL was analyzed for
(D) Lung sections were stained with periodic acid Schiff (PAS) reagent to visualiz
(E) IL-5 concentration in BAL supernatants of mice treated as described in (C).
(F) Cytokine production of in vitro restimulated MLN cells taken on day 20 and c
(G) Serum OVA-specific Igs were determined by ELISA.
(H) Mice were sensitized with OVA or OVA mixed with different doses of UA cryst
with OVA aerosols on days 17–19. On day 20, the number of eosinophils was as
(I) Lung sections stained with PAS. Scale bar represents 100 mm.
(J) IL-5 in BAL supernatant.
(K) Serum OVA-specific Igs determined by ELISA.
Data are shown as mean ± SEM, *p < 0.05, **p < 0.01, n = 4–8 mice/group. Experby treatment with uricase (Figure 1B). Uricase treatment during
priming to OVA+alum eliminated Th2 cell-dependent bronchoal-
veolar lavage (BAL) fluid eosinophilia (Figure 1C), peribronchial
inflammation and goblet cell hyperplasia (Figure 1D), secretion
of IL-5 in the BAL fluid (Figure 1E), production of IL-4, IL-5,
IL-10, and IL-13 (but not IFN-g) in mediastinal LN (MLN) cultures
restimulated with OVA antigen for 3 days ex vivo (Figure 1F), and
production of serum OVA-specific IgE and IgG1 (Figure 1G).
There was also a trend toward reduced production of IgG2a by
uricase treatment. OVA+alum injection also led to release of
extracellular ATP, another DAMP known to activate the NLRP3
inflammasome via the P2X7 receptor (Mariathasan et al., 2006)
and promote Th2 cell immunity (Idzko et al., 2007), yet its neutral-
ization or use of P2rx7/ mice did not reveal a contribution to
Th2 cell immunity (Figure S2).
To address whether UA was also sufficient to induce Th2 cell
immunity, we injectedOVA admixedwith UA crystals. Compared
with control mice receiving OVA, this treatment dose depen-
dently increased airway eosinophilia (Figures 1H and 1I), goblet
cell hyperplasia (Figure 1I), IL-5 in BAL fluid (Figure 1J), and
production of OVA-specific IgE, IgG1, and IgG2a (Figure 1K).
Injection of OVA+UA also led to increased production of IL-4,
IL-5, and IL-10, but not IFN-g, in MLN cells (data not shown).
These responses were of similar strength as those induced by
injection of OVA+alum (Figures 1C–1E). Therefore, UA is neces-
sary and sufficient for Th2 cell response development to intra-
peritoneal injection of harmless antigen, identifying it as a potent
Th2 cell adjuvant.
Endogenous UA Is Necessary for Development
of Th2 Cell Immunity to HDM Allergen in the Absence
of Adjuvant
We next investigated the involvement of endogenous UA in
response to complex and relevant allergens in the airways. A
single intranasal HDM administration in naive mice resulted in
a rapid increase in UA concentration in BAL fluid and lung (Fig-
ure 2A) compared with PBS. Mice sensitized and challenged
with HDM developed features of allergic asthma, like BAL fluid
and lung eosinophilia, lymphocytosis, goblet cell hyperplasia
(Figures 2B and 2D), and airway hyperresponsiveness (AHR) to
increasing doses of metacholine (Figure 2C). Intratracheal
administration of uricase on day 0 at the time of sensitization
neutralized the increase in UA (Figure 2A) and strongly reduced
airway lymphocytosis and eosinophilia and AHR (Figures 2A–
2D). To explain the mechanism of action, we evaluated thereated or not with uricase.
VA or OVA+alum i.p. on day 0. On day 7, mice were boosted with OVA i.p. and
the presence of eosinophils.
e goblet cell metaplasia. Scale bars represent 100 mm.
ultured for 3 days in vitro in the presence of OVA.
als i.p. on day 0. On day 7, all mice were boosted with OVA i.p. and challenged
sessed in BAL.
iments were repeated twice; data shown are representative of all experiments.
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Figure 2. Uric Acid Plays a Key Role in Sensitization to House Dust Mite Allergen via the Airways
(A) C57BL/6 mice were sensitized i.n. with PBS or HDM and treated or not with uricase, and UA concentration was determined 2 hr later in the BAL and
lung homogenates.
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Uric Acid as a Trigger of Th2 Cell Immunityproduction of cytokines known to promote eosinophilic inflam-
mation and Th2 cell immunity (Hammad and Lambrecht, 2008;
Saenz et al., 2008). As already reported, the concentration of
GM-CSF, TSLP, and IL-25 (Figure 2E) were increased in the
lungs of animals exposed to a single HDM injection, compared
with PBS (Hammad et al., 2009). However, this innate cytokine
response was severely reduced in mice treated with uricase.
House dust mite-driven Th2 cell development relies on antigen
presentation by inflammatory Ly6ChiCD11b+ DCs that take up
antigen in the lung and migrate to the MLN (Hammad et al.,
2010). To address antigen uptake and migration of these inflam-
matory DCs, we injected fluorescent OVA together with HDM
allergen. In mice injected with OVA+HDM, migratory DCs
carrying fluorescent cargo were easily identified in the MLN.
After uricase treatment, this migration was strongly reduced
(Figure 2F).
We next searched for the source of increased UA produc-
tion. Within 2 hr after HDM administration, there was increased
immunoreactivity for UA in airway epithelial cells and major
histocompatibility complex II (MHCII)-positive alveolar macro-
phages and recruited monocytes (Figures 2G) compared to
mice administered PBS. Strong UA immunoreactivity was
seen along the basement membrane of HDM-exposed mice.
Although UA release occurs in response to necrotic cell death,
UA is also produced as a pulmonary defense mechanism to
oxidative damage, through increased xanthine oxidoreductase
(XOR) enzyme activity inside peroxisomes (Vorbach et al.,
2003). In bronchial epithelial cells and MHCII-positive cells,
HDM exposure induced enhanced staining for the 70 kDa
peroxisomal marker PMP70, suggestive of peroxisomal
biogenesis (Figure 2H; Imanaka et al., 1999). The expression
of XOR was increased in BAL cells of HDM-exposed mice
2 hr after instillation compared with PBS (Figure 2I). We (Ham-
mad et al., 2009) and others (Phipps et al., 2009; Trompette
et al., 2009) recently identified TLR4 signaling as a crucial early
trigger for the innate pro-Th2 cell immune response to aller-
gens. In contrast to the alum-induced increase of UA in the
peritoneal lavage (Figure S1), HDM-driven production of UA
was severely reduced in C57BL/6 Tlr4/ mice (Figure 2J),
suggesting that triggering of TLR4 by HDM is necessary for
activation of XOR and UA production in the airways in
response to allergens.(B) Mice were sensitized i.n. on day 0 with PBS, HDM, or HDM+uricase and ch
presence of eosinophils and lymphocytes.
(C) Lung function, as determined by invasive measurement of airway resistance (R
with untreated, HDM-sensitized group; *p < 0.05 compared with nonsensitized g
(D) PAS staining of lung sections. Scale bars represent 100 mm.
(E) Production of GM-CSF, IL-33, TSLP, and IL-25 in lung homogenates of mice
(F) Antigen uptake and migration of inflammatory CD11b+Ly6C+ DCs to the me
absence of HDM, and effect of treatment with uricase. ***p < 0.005 compared w
(G) Fluorescence staining of uric acid (red) and MHCII (green) in lungs of animals
Scale bars represent 10 mm.
(H) Fluorescence staining of the peroxisomal marker PMP70 (red) and MHCII (g
terstained with DAPI (blue). Scale bars represent 20 mm.
(I) Expression of XOR mRNA normalized for HPRT by real-time quantitative RT-P
(J) Increased production of UA depends on TLR4 triggering by HDM. In this expe
measured 2 hr later. Data are shown as mean ± SEM, *p < 0.05, n = 4–8 mice/gr
Experiments were repeated twice. Data shown are representative of all experimeUric Acid Is Increased in Allergen-Challenged Human
Asthmatics and Mice
To study whether our findings had any bearing on human
asthma, BAL fluid was collected from 21 asthmatic subjects,
10min and 24 hr after segmental challenge with saline or specific
allergens (rye, birch, or HDM). There was no difference in the
concentration of UA between saline- and allergen-challenged
segments after 10 min. In contrast, 24 hr after allergen provoca-
tion, the UA concentration was markedly elevated in the BAL
fluid from allergen- compared to saline-challenged segments
(Figure 3A). This increase in UA concentration correlated with
the influx of eosinophils and lymphocytes into the BAL (Figures
3B and 3C). Subgroup analysis of patients showing a minor
rise in UA showed that this was not correlated with the type of
allergen used nor the concentration of IgE in the serum, but
rather on maintenance inhaled corticosteroid (ICS) therapy up
to 7 days prior to allergen challenge (Figure S3).
To test whether UA neutralization would have any therapeutic
potential, we again turned to the mouse model of HDM-
induced asthma. Mice were first sensitized to HDM and were
treated with uricase prior to each allergen challenge. HDM
challenge induced a rise in UA in BAL fluid, still measurable
3 days after the last of five challenges (Figure 3D), and uricase
treatment during challenge reduced airway eosinophilia (Fig-
ure 3E), metacholine-induced AHR, and IL-13 concentration
in the BAL fluid (Figures 3F and 3G). Allergen challenge induced
high numbers of eosinophils in the BAL fluid, which indicates
that cellular death of recruited eosinophils could be a trigger
for UA production. Uricase treatment had similar effects in
a milder sensitization model in which only 20% of the number
of eosinophils was recruited compared with the high dose
sensitization model (Figure S4), arguing against the idea that
UA plays a role only when there would be massive cellular
recruitment and death.
UACrystals, Alum, and HDMPromote Th2 Cell Immunity
in the Absence of NLRP3 Inflammasome Activation
Although UA is the prototypical activator of the NLRP3 inflam-
masome and several groups (Eisenbarth et al., 2008; Franchi
and Nu´n˜ez, 2008; Hornung et al., 2008; Kool et al., 2008a;
McKee et al., 2009) have shown that alum directly triggers
NLRP3 in vitro, there is considerable controversy whether theallenged i.n. with HDM on days 7–11. On day 14, BAL was examined for the
) in response to increasing concentrations of metacholine. #p < 0.05 compared
roup.
2 hr after the i.n. administration of PBS, HDM, or HDM+uricase.
diastinal LN, 24 hr after intranasal injection of OVA-AF647 in the presence or
ith OVA; **p < 0.05 compared with OVA+HDM.
exposed for 2 hr to HDM or PBS. Nuclei were counterstained with DAPI (blue).
reen) in lungs of animals exposed for 2 hr to HDM or PBS. Nuclei were coun-
CR.
riment C57BL/6 WT or Tlr4/ mice received HDM, and UA concentration was
oup.
nts.
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Figure 3. Involvement of UA in Ongoing Allergic Airway Inflammation in Human and Mouse
(A) UA concentration in BAL of asthmatic patients 10 min or 24 hr after segmental bronchial allergen or saline challenge.
(B and C) Correlation of UA concentration with the number of BAL eosinophils (B) or lymphocytes (C) 24 hr after allergen challenge.
(D) Concentration of UA in BAL 3 days after the last of five HDM challenges in HDM-sensitized mice.
(E) Treatment of HDM-sensitized mice with uricase (10 U) concurrent with each allergen challenge reduced airway eosinophilia, measured 3 days after the last
challenge.
(F) Effect of uricase treatment prior to allergen challenge on AHR to increasing doses of metacholine.
(G) Concentration of IL-13, a cytokine associated with induction of AHR, in BAL.
Data are shown as mean ± SEM, *p < 0.05, **p < 0.01, n = 4–8 mice/group. Experiments were repeated twice. Data shown are representative of all experiments.
Immunity
Uric Acid as a Trigger of Th2 Cell Immunityinflammasome-IL-1b pathway is necessary for adjuvanticity
in vivo (Franchi and Nu´n˜ez, 2008; Williams et al., 2010). We
therefore studied the involvement of this pathway in UA-driven
Th2 cell immunity in vivo. Wild-type C57BL/6 mice immunized
with OVA+UA showed a marked increase in eosinophilia and
lymphocytosis in BAL (Figures 4A–4E), and this response was
not affected in Nlrp3/ or Pycard/ mice, lacking essential
components of the inflammasome complex (Martinon et al.,
2006). Because there might be inflammasome-independent532 Immunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc.pathways to generate IL-1b, we also immunized mice lacking
the IL-1R or mice lacking the critical IL-1R signaling interme-
diate MyD88. It has also been suggested that UA crystals
signal via TLR4, although this could be due to contaminating
endotoxin. Strikingly, Il1r/, Tlr4/, and Myd88/ mice all
developed normal Th2 cell immunity to OVA+UA (Figures 4C–
4E). We also studied whether development of Th2 cell immunity
and asthma in response to OVA+alum relied on Nlrp3. Contrary
to a recent report (Eisenbarth et al., 2008), we observed that
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Figure 4. Uric Acid-Mediated Adaptive Th2 Cell Responses Do Not Require the IL-1-Inflammasome Axis
C57BL/6 mice were administered OVA mixed or not with UA crystals (UA) on day 0, boosted on day 7 with OVA intraperitoneally (i.p.), and challenged with OVA
aerosols on days 17–19.
(A) Cellular composition in the BAL of WT and Nlrp3/ mice.
(B) Cellular composition in the BAL fluid (BALf) of WT and Pycard/ mice.
(C) Cellular composition in the BALf of WT and Tlr4/ mice.
(D) Cellular composition in the BALf of WT and Myd88/ mice.
(E) Cellular composition in the BAL of WT and Il-1r/ mice.
Data are shown as mean ± SEM, *p < 0.05, **p < 0.01, n = 4–6 mice/group. Experiments were repeated 2–3 times. Data shown are representative of all
experiments.
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Uric Acid as a Trigger of Th2 Cell ImmunityTh2 cell-dependent asthmatic airway inflammation developed
normally in Nlrp3/ mice immunized with OVA+alum (Fig-
ure S5). To address whether HDM-driven asthma was depen-
dent on these pathways, Nlrp3/, Pycard/, and P2rx7/
mice were sensitized and challenged with HDM via the airways
but showed no reduction in Th2 cell-dependent eosinophilia
(Figure S6). As already reported, Myd88/ and Tlr4/ mice
had reduced HDM-driven airway inflammation (data not shown;
Hammad et al., 2009, 2010). In conclusion, the prototypical Th2cell stimuli alum and HDM, like UA crystals, do not rely on the
NLRP3 inflammasome to induce Th2 cell-adaptive immunity
leading to allergic airway inflammation.
UA Crystals Recruit Inflammatory DCs that Are
Necessary and Sufficient for Th2 Cell Immunity
Twenty-four hours after injection of OVA-Alexa Fluor 647+UA,
there was a strong increase in the number of inflammatory
Ly6ChiCD11b+ monocytes and inflammatory Ly6C+CD11b+Immunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc. 533
Figure 5. Inflammatory Monocytes and Dendritic Cells Are Critical for the Uric Acid-Mediated Adaptive Th2 Cell Responses
(A) C57BL/6mice receivedOVA-AF647mixed or not with UA crystals intraperitoneally (i.p.), and 24 hr later the peritoneal lavagewas examined for the presence of
OVA+CD11b+Ly6Chi inflammatory monocytes and DCs.
(B) OVA+ inflammatory monocytes and DCs were analyzed for the expression of CD86.
(C) C57BL/6 mice were treated with Gr-1 or control antibodies (500 mg/mouse) on day 1, 0, 1, 2. On day 0, mice were treated with OVA mixed or not with UA
crystals (UA), boosted on day 7 with OVA i.p., and challenged with OVA aerosols on days 17–19. Cellular composition in the BALf is shown.
(D) C57BL/6 Cd11c-DTR mice were treated with diphtheria toxin (100 ng/mouse i.p.) on day 1. On day 0, mice were treated with OVA mixed or not with UA
crystals, boosted on day 7 with OVA i.p., and challenged with OVA aerosols on days 17–19. Cellular composition in the BALf was determined by flow cytometry.
(E) BALB/c mice were sensitized by intratracheal instillation of 1 3 106 unpulsed or OVA-pulsed bone marrow-derived GM-CSF DCs with or without uricase.
On days 10–12, mice were challenged with OVA aerosols. Cellular composition in the BAL is shown.
Data are shown as mean ± SEM, *p < 0.05, **p < 0.01, n = 4–6 mice/group. Experiments were repeated 2–3 times. Data shown are representative of all
experiments.
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Uric Acid as a Trigger of Th2 Cell ImmunityDCs that had ingested OVA in the peritoneal cavity compared
with mice injected with OVA-AF647 alone (Figure 5A), and these
recruited cells had higher expression of the costimulatory mole-
cule CD86 (Figure 5B). Although recruitment and activation of
DCs suggests a functional role for these cells in the UA effect,
we still wanted to address whether DCs are really necessary
for mediating Th2 cell immunity, because recent work suggested
that DCs are poor inducers of Th2 cell immunity, whereas baso-
phils readily are (Perrigoue et al., 2009; Sokol et al., 2009; Yosh-
imoto et al., 2009).We therefore injectedOVA+UA inCd11c-DTR
C57BL/6 mice, together with diphteria toxin (DT) to deplete DCs534 Immunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc.(Jung et al., 2002). DT injection in Tg mice abolished airway
eosinophilia induced by OVA+UA (Figure 5D). This effect was
also seen when we injected an antibody to Ly6C/G (Gr1) that
depletes inflammatory monocytes (Figure 5C), but in this setting
one cannot exclude that neutrophils play an additional role. To
finally demonstrate that inflammatory DCs are sufficient to
induce Th2 cell immunity, we injected GM-CSF-cultured OVA-
pulsed DCs (a model to generate inflammatory type DCs) into
the peritoneal cavity, followed by OVA challenge to the lung.
Intraperitoneal injection of OVA-pulsed DCs, but not unpulsed
DCs, was able to prime for an eosinophilic Th2 cell response
Immunity
Uric Acid as a Trigger of Th2 Cell Immunity(Figure 5E). However, treatment with uricase did not inhibit Th2
cell development induced by DC injection, demonstrating that
the immunostimulatory effects of UA are upstream of DC activa-
tion in vivo. These experiments also demonstrate that uricase
treatment does not have a generalized off-target suppressive
effect on Th2 cell polarization, but rather inhibits inflammatory-
type DC recruitment and activation.
UA Activates DCs and Th2 Cell Immunity
in a Syk- and PI3-Kinase d-Dependent Manner
The above data implied that DCs are a crucial intermediate cell
type inmediating the Th2 cell immune response toOVA+UA (Fig-
ure 5) but also that the NLRP3-ASC-IL1-R axis were not involved
in this process in vivo (Figure 4). UA crystals mixed with OVA
in vitro were able to induce the secretion of bioactive cleaved
IL-1b in inflammatory DCs, and this effect was completely
absent in cells of Nlrp3/ mice, essentially showing that UA
does trigger this inflammasome pathway in DCs. However,
OVA+UA also induced secretion of IL-6 and TNF-a in inflamma-
tory DCs and these responses were not abolished in Nlrp3/
mice. Strikingly, OVA+UA did not induce production of the Th1
cell instructive cytokine IL-12. Recently, via atomic force micros-
copy, UA crystals were shown to directly engage cholesterol-
rich cellular membranes of DCs in a receptor-independent
manner, leading to recruitment and activation of spleen tyrosine
kinase (Syk) on membrane-associated immunoreceptor tyrosine
activation motifs (Ng et al., 2008). Other studies have also
identified Syk signaling and downstream PI3-kinase activation
as an essential intermediate of UA-induced human neutrophil
activation (Desaulniers et al., 2001; Popa-Nita et al., 2007).
When the in vitro Syk inhibitor piceattanol was added, UA+OVA
no longer induced IL-1b, IL-6, or TNF-a production in inflamma-
tory DCs, suggesting that this pathway was more broadly
involved in inducing cytokine production in DCs (Figure 6A).
Oral administration of the Syk inhibitor BAY61-3606 reduced
influx of OVA-positive inflammatory Ly6C+CD11b+ monocytes
in the peritoneum 24 hr later (Figure 6B). Signaling downstream
of Syk has been shown to involve interaction of p85 with p110d
subunits of PI3-kinase (Popa-Nita et al., 2007). The number of
OVA+Ly6C+CD11b+ monocytes 24 hr after injection of OVA+UA
was strongly reduced in mice expressing a catalytically inactive
form of the p110d subunit of PI3-kinase (D910A) (Figure 6C). We
finally addressed whether Syk and downstream PI3-kinase
d signaling was important for development of adaptive Th2 cell
immunity to OVA+UA. Oral administration of BAY61-3606
compound strongly reduced airway lymphocytosis and eosino-
philia (Figure 6D). Accordingly, OVA+UA did not induce Th2
cell immunity in Pik3cdD910A mice (Figure 6E), although this
finding could also reflect effects on other cells like mast cells
(Ali et al., 2004). To address whether the inibition of Syk was
specifically acting at the level of DCs, we took a genetic
approach and immunized Cd11cCre 3 Sykbfl/fl mice specifically
lacking Syk in CD11chi cells (unpublished observations) or
control mice with OVA or OVA+UA crystals. Upon OVA chal-
lenge, the degree of reduction in airway eosinophilia in these
Sykb/ DC mice was of similar magnitude as those treated
with a pharmacological Syk antagonist, suggesting indeed that
Syk triggering in DCs is crucial for mounting Th2 cell immunity
to UA (Figure 6F).DISCUSSION
Although UA is a known trigger for acute neutrophilic inflamma-
tion (Martinon et al., 2006), we here identified its role as a promo-
tor of Th2 cell-dependent allergic inflammation. The release of
UA was seen in patients with allergic asthma challenged with
relevant allergen, in naive and sensitized mice exposed to the
prototypical Th2 cell inducer and relevant HDM allergen, and
after injection of the prototypical Th2 cell adjuvant alum.
The Th2 cell-inducing capacity of UA occurred independently
from its actions on the NLRP3-ASC-IL-1-MyD88 axis. UA is
released upon alum administration in vivo, but not in vitro, so
these findings could explain the controversy that has arisen as
to whether triggering NLRP3 inflammasome activation is crucial
for alum adjuvanticity (Marrack et al., 2009). All authors that have
studied the involvement of NLRP3 agree that NLRP3, PYCARD
(ASC), and caspase-1 are crucial for alum-induced IL-1b secre-
tion in vitro and in vivo, but this does not automatically imply that
all adjuvant effects of alummust therefore occur via this pathway
(Franchi and Nu´n˜ez, 2008; Li et al., 2007, 2008; McKee et al.,
2009). Our findings suggest that UA released upon alum injection
in vivo is by itself sufficient to induce Th2 cell adjuvant effects
that do not depend on the inflammasome-IL-1R pathway. It
has indeed long been known that alum-induced asthma models
do not rely on IL-1R signaling (Piggott et al., 2005; Schmitz et al.,
2003) nor on the downstream essential adaptor molecule MyD88
(Piggott et al., 2005). One report has suggested that Nlrp3 is
absolutely required for alum to induce Th2 cell immunity to
OVA and subsequent development of allergic type inflammation
of the lung (Eisenbarth et al., 2008), at odds with findings in the
current report. These authors, however, also demonstrated
that the effects of alum were MyD88 independent, arguing
against a role for IL-1R signaling, given the crucial role of
MyD88 as a signaling intermediate of the IL-1R pathway. These
differences could be explained best by subtle differences in anti-
gens used, type of alum used, and timing of analysis. Also we
have described previously that NLRP3, IL-1, and MyD88 are
involved in the early innate response of DCs to alum injection
in the peritoneal cavity, but clearly these reactions are redundant
with other pathways to induce Th2 cell immunity to OVA (Fig-
ure 4), and their elimination never leads to complete abolition
of DC activation or subsequent T cell activation (Kool et al.,
2008a, 2008b).
The most striking finding of our paper is that UA is also
released upon primary exposure of the lung to HDM, as well as
upon allergen challenge in already sensitized human asthmatics
and mice. Experiments with the UA-degrading enzyme uricase
furthermore showed that endogenously released UA promotes
Th2 cell sensitization by amplifying the production of innate
pro-Th2 cytokines that instruct DCs to induce Th2 cell immunity,
like TSLP, GM-CSF, and IL-25 (Barrett and Austen, 2009; Lam-
brecht and Hammad, 2009), as well as stimulating the activation
of inflammatory DCs. Many reported that this innate pro-Th2
cytokine release and DC activation depends on TLR4 triggering
on lung epithelial cells via endotoxin contained in the HDM
allergen (Hammad et al., 2009, 2010; Trompette et al., 2009).
We now show that TLR4 triggering is functionally connected to
the induction of UA production in epithelial cells and macro-
phages.Most probably this occurs via induction of the enzymaticImmunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc. 535
Figure 6. UA Crystals Induce Th2 Cell Immunity through Spleen Tyrosine Kinase and PI3-Kinase d
(A) Bone marrow-derived DCs were cultured in GM-CSF fromWT andNlrp3/mice and preincubated with the Syk inhibitor piceatennol for 30 min (50 mM), then
pulsed with OVA (100 mg/ml) with or without UA crystals (250 mg/ml) for 3 hr, after which cytokine concentration was determined in the cell supernatant.
(B) C57BL/6 mice were treated twice a day on days 1 and 2 orally with the specific Syk inhibitor BAY61-3606 (Yamamoto et al., 2003) and injected on day
0 with OVA-AF647 mixed or not with UA crystals intraperitoneally (i.p.). 24 hr later, the peritoneal lavage was examined for the presence of OVA+ inflammatory
monocytes.
(C) Pik3cdD910A orWTC57BL/6mice were injected with OVA-AF647mixed or not with UA crystals (UA) i.p., and 24 hr later the peritoneal lavage was examined for
the presence of OVA+ inflammatory monocytes.
(D) C57BL/6 mice were treated twice a day on days1 and2 orally with the specific Syk inhibitor BAY61-3606 . On day 0, mice were treated with OVAmixed or
not with UA crystals, boosted on day 7 with OVA i.p., and challenged with OVA aerosols on days 17–19. Cellular composition in the BAL is shown.
(E) Cellular composition in the BALf ofWT andPik3cdD910Amice, which have been sensitized with OVA+UA crystals and challenged with OVA aerosol as decribed
in (D), is depicted.
(F) Cellular composition in the BAL of Sykb/ DC and Sykb+/+ DC chimeric mice, which were sensitized with OVA+UA crystals and challenged with OVA as
described in (D).
Data are shown as mean ± SEM, *p < 0.05, **p < 0.01, n = 4–6 mice/group, representative of at least two experiments per panel.
Immunity
Uric Acid as a Trigger of Th2 Cell Immunityactivity of the rate-limiting uric acid-synthesizing enzyme
xanthine oxidoreductase, leading to production of UA inside
peroxisomes. Alternatively, increased UA concentration could
also result from reduced catabolism from urate oxidase.
Although we have not formally investigated the mechanisms of536 Immunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc.TLR4-driven induction of UA production, it is known that UA is
found in the lining fluid of the airway epithelial layer in vivo and
is induced in response to various types of oxidative stress like
ozone exposure or respiratory viral infection (Akaike et al.,
1990; Papi et al., 2008). The xanthine oxidoreductase gene is
Immunity
Uric Acid as a Trigger of Th2 Cell Immunityinduced as part of an innate immune response to various stimuli
like LPS, tissue hypoxia, and early innate cytokines like IL-1, and
the promotor region contains an NF-kB control element (Has-
soun et al., 1998; Vorbach et al., 2003). How exactly locally
released UA affects the innate cytokine production by epithelial
cells is at present unclear, nor do we have any indication that
UA concentration would be so high that UA crystals are formed
in the lung lining fluid. Because of physicochemical constraints,
we have been unable to transfer UA crystals to the lungs of mice
to directly probe for effects on epithelial cells without mortality of
the mice. One possiblility that needs further exploration is the
fact that the antioxidant properties of UA in the lung lining fluid
affect the potential of bronchial epithelial cells to synthesize,
correctly fold, and secrete proteins, processes sensitive to
oxidative stress (Santos et al., 2009).
We have also reported previously that ATP is released in
the airways of OVA-challenged sensitized mice, as well as
allergen-challenged patients, indicating that a DAMP can
contribute to asthma pathogenesis (Idzko et al., 2007). Because
ATP is a well-known activator of the NLRP3 inflammasome
(Franchi et al., 2007), acting via the P2X7 purinergic receptor
that is a potassium efflux channel, it made sense to address
whether either alum-induced or HDM-induced asthma relied
on P2X7. Experiments in P2rx7/ mice did not, however, reveal
a crucial role of this receptor in asthma development, again
arguing against a predominant role of NLRP3 in asthma.
However, there are many ways by which ATP can activate innate
and structural cells of the lung to promote asthma and Th2 cell
development, because the purinergic receptor family is very
broad and widely expressed among others on eosinophils
(Kobayashi et al., 2010).
Recently, several groups studying Th2 cell response induction
to the protease allergen papain or to gastrointestinal parasites
have reported that DCs are poor inducers of Th2 cell immunity
that are neither sufficient nor required for Th2 lymphocyte differ-
entiation, basophils being clearly superior (Perrigoue et al., 2009;
Sokol et al., 2009; Yoshimoto et al., 2009). However, it was
recently also shown that for HDM sensitization, inflammatory
DCs are the antigen-presenting cells that provide the first
instruction to Th2 cell development, whereas basophils act to
enhance these responses (Hammad et al., 2010). Given the
fact that the relative contribution of DCs versus basophils seems
to depend on the type of Th2 cell stimulus or the route of injection
(Tang et al., 2010), it was therefore of interest to study the
involvement of DCs in mediating the Th2 cell adjuvant activities
of UA injected into the peritoneal cavity. Employing the logic of
Koch’s postulates, we first found that inflammatory type DCs
and their monocytic precursors were recruited to the site of UA
injection, that depletion of CD11chi dendritic cells abolished
UA-driven Th2 cell responses, and that adoptive transfer of
inflammatory DCs to the peritoneal cavity was sufficient to
induce Th2 cell immunity. Moreover, because we did not
observe basophil recruitment to the draining lymph nodes of
the peritoneal cavity (data not shown), we believe that these
experiments are sufficient proof that DCs are the cells driving
Th2 cell immunity to OVA+UA.
Recently, UA crystals were shown to directly engage choles-
terol-rich cellular membranes of DCs in a receptor-independent
manner, leading to activation of Syk and downstream PI3Ksignaling (Ng et al., 2008). Experiments with in vitro and in vivo
Syk inhibitors, as well as kinase-dead Pik3cdD910A mice,
revealed that this pathway was relevant for early in vivo recruit-
ment of inflammatory DCs to the site of injection and in vivo
development of Th2 cell immunity to OVA+UA. Although these
manipulations could also affect other cells, the use of mice
specifically lacking Syk expression in DCs allowed us to
conclude that at least the DC is a predominant sensor of UA
crystals. How exactly DCs exposed to UA subsequently polarize
Th2 cell immune responses is more speculative, but again prob-
ably involves Syk signaling. We observed that DCs exposed to
OVA+UA produced IL-1b, IL-6, and TNF-a in the absence of
the polarizing cytokine IL-12, in a Syk-dependent manner. We
and others have previously reported that absence of IL-12
production is a prerequisite for inflammatory DCs to be able to
induce Th2 cell immunity, because retroviral overexpression of
IL-12 abolishes DC-driven Th2 cell development and subse-
quent asthma (Eisenbarth et al., 2002; Kuipers et al., 2004),
whereas others reported that IL-6 and TNF-a are all involved in
promoting DC-driven Th2 cell development in asthma (Dodge
et al., 2003; Ebeling et al., 2007; Eisenbarth et al., 2002; Rinco´n
et al., 1997). One report demonstrated that Syk signaling in DCs
is crucial for Th2 cell-dependent asthma development driven by
adoptive transfer of DCs, but it is unclear how this relates to
polarizing cytokine secretion (Matsubara et al., 2006). Further
definitive experiments will involve neutralization of individual
cytokines to address these issues in detail.
In conclusion, we have identified an unexpected role for UA as
a crucial initiator and amplifier of Th2 cell immunity and allergic
inflammation in the mouse by activating inflammatory DCs. At
the same timewe have identified a pathway of immune activation
by UA crystals that is independent of their well-known capacity
to trigger the NLRP3 inflammasome. The fact that neutralization
of uric acid at the time of allergen challenge reduces the salient
features of asthma, and the fact that increased UA concentra-
tions are found in patients after allergen challenge, open up the
prospects that this pathway could be used for novel therapeutics
in asthma.
EXPERIMENTAL PROCEDURES
Human Subjects
Twenty-one nonsmoking patients with mild allergic asthma (Table S1) were
recruited based on airway hyperresponsiveness, positive allergen skin prick
tests, elevated total or specific IgE concentrations, and a dual reaction after
allergen challenge (Lommatzsch et al., 2006). The calculation of the individual
provocation dose was performed based on responsiveness to inhalation
allergen challenge (Lommatzsch et al., 2006). Inhaled and segmental allergen
challenges were separated by at least 4 weeks. Segmental allergen challenge
was performed as described (Lommatzsch et al., 2006). Corticosteroids were
withdrawn at least 7 days before challenge. Patients gave their written
informed consent, and he study was approved by the local ethics committee
of the University Hospital Rostock, Germany.
Mice
BALB/c mice and C57BL/6 mice (6–9 weeks old) were purchased from Harlan
(Zeist, The Netherlands). Nalp3/, Pycard/, Tlr4/, P2rx7/, Myd88/,
Il1r/, and WT C57BL/6 mice (6–10 weeks old) were kindly provided by J.
Tschopp (University of Lausanne, Swizterland) and B. Ryffel (University of
Orleans, France). Pik3cdD910A were kindly provided by B. Vanhaesebrouck
(Queen Mary University London). To generate mice lacking Syk specifically
in DCs, Cd11cCre mice were crossed to Sykbfl/fl mice (unpublishedImmunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc. 537
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mice, by sublethally irriaditing C57BL/6 mice (5Gy), followed 4 hr later by intra-
venous (i.v.) injection of 23 106 BM cells. Chimeric mice were used 10 weeks
after hematopoietic reconstitution. All experiments were approved by the
animal ethics committee at Ghent University and Erasmus University Medical
Center.
Monosodium Urate Crystal Preparation
MSU crystals were prepared as described (Chen et al., 2006). In brief, satu-
rated uric acid (5 mg/mL, Sigma) in 0.1 M borate buffer (pH 8.5) was incubated
at room temperature for 48 hr. After harvesting the crystals, they were washed
with alcohol and acetone and air-dried for at least 2 days. Crystals were
between 5 and 25 mm long and contained <0.005 EU/mL endotoxin.
Treatment with Uricase
For intraperitoneal injections, mice received 50 U of uricase (Sigma-Aldrich)
or rasburicase (Sanofi-Synthelabo) in 100 ml PBS 5 min prior to injection of
OVA+alum. For intrapulmonary administration, HDM was mixed with 10 U
uricase and injected intranasally into 40 ml.
Induction of Allergic Airway Inflammation
To test the adjuvant properties of MSU crystals, mice were injected intraperi-
toneally (i.p.) with 10 mg of OVA (Worthington) mixed with increasing amounts
of MSU crystals (1–7.5 mg in 500 ml). Mice were boosted i.p. on day 7 with OVA
and challenged with OVA aerosols (Sigma, 1% for 30 min) on days 17–19. On
day 20, mice were analyzed for the presence of Th2 cell-dependent eosino-
philic airway inflammation.
To induce HDM-driven eosinophilic airway inflammation, anesthetized mice
were administered intranasaly (i.n.) with 40 ml of house dust mite extracts
(100 mg, Greer Laboratories) on day 0 and challenged on days 7–11 with
HDM. On day 14, mice were sacrificed and different parameters were
analyzed. Assessment of bronchial hyperreactivity and histological analysis
of goblet cell hyperplasia was measured as described previously (Hammad
et al., 2009).
Immune Analysis
To determine the degree of airway eosinophilia, bronchoalveolar lavages (BAL)
were performed by injecting 1ml of PBS containing 0.01mMEDTA. Cells were
stained with FITC anti-I-Ad and I-Ed, PE-labeled anti-Siglec F, PerCp-labeled
anti-CD3 and anti-CD19, and APC-labeled anti-CD11c (all from BD Biosci-
ences). Peritoneal inflammatory cells were stained as described (Kool et al.,
2008b). Data were collected on a FACS Aria II (Becton Dickinson) and were
analyzed with FlowJo software (Treestar, Inc.).
The concentration of UA (Amplex Red Uric Acid; Uricase assay, Invitrogen),
GM-CSF, IL-33, TSLP, and IL-25 (all R&D Systems) was measured in BAL fluid
and lung homogenates by ELISA 2 and 24 hr after HDM administration. The
concentration of Th2 cytokines in BAL fluids was measured 24 and 72 hr after
the last challenge, respectively.
OVA-specific IgG1, IgE, and IgG2aweremeasured in sera ofmice sensitized
and challenged with OVA by ELISA (antibodies from R&D Systems).
Uric Acid Staining in the Lung
Two hours after the i.n. administration of PBS or HDM, lungs were inflated with
PBS and OCT and frozen at 80C. Ten mm thick sections were fixed with 4%
formaline for 10 min and stained with rabbit anti-uric acid antibodies (Abcam)
followed by Cy3-labeled goat anti-rabbit antibodies (Jackson Laboratories),
blocking with rabbit serum, biotin-labeled anti-peroxisomal membrane protein
70 (Genetex), and FITC-labeled anti-MHCII (BDBioscience), followed by strep-
tavidin Alexa Fluor 647. Nuclei were counterstained with 40,60diamidino-2-phe-
nylindole (DAPI). Images were collected on a Zeiss LSM 710 equipped with
a Ar 488 nm laser, a He-Ne 561 nm laser, a He-Ne 633 nm laser, and a Mai
Tai femtosecond-pulsed laser tuned at 800 nm to excite DAPI. Images were
analyzed with Imaris (Bitplane).
qPCR on Xanthine Oxido Reductase
RNA was isolated from BAL cells with High Pure RNA Isolation Kit (Roche)
with on-column DNase I treatment. 100 ng RNA was reverse transcribed
with Transcriptor High Fidelity cDNA Synthesis Kit (Roche). Quantitative538 Immunity 34, 527–540, April 22, 2011 ª2011 Elsevier Inc.PCR was performed with LightCycler 480 Probes Master (Roche) and primers
(xanthine oxidoreductase; forward, AGGGATTCCGGACCTTTG; reverse,
GCAGCAGTTTGGGTTGTTTC) and probe mixes (probe 69; Roche). PCR
conditions were 10 min at 95C, followed by 45 cycles of 10 s at 95C and
50C for 1 min with a LightCycler 480 Instrument (Roche). PCR amplification
of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase
(HPRT) was performed during each run for each sample to allow normalization
between samples.
Statistical Analysis
For all experiments unless stated otherwise, the difference between groups
was calculated with the Mann-Whitney U test for unpaired data (GraphPad
Prism version 4.0; GraphPad, San Diego, CA). Comparison of the human
BAL fluid UA concentration was performed with the Wilcoxon-signed rank
test. Correlations between the human data were tested with Pearson’s
correlation test. Differences were considered significant when p < 0.05 (*),
p < 0.01 (**), or p < 0.005 (***).
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